IL152927A - 1- [3- (7,6-Dihydro-1-methyl-7-oxo-3-profile-1H-pyrazolo [3,4-d] pyrimidin-5-yl) - (Phenyl converted at position 4) Sulfonyl] -4-methyl piperazines - Google Patents

1- [3- (7,6-Dihydro-1-methyl-7-oxo-3-profile-1H-pyrazolo [3,4-d] pyrimidin-5-yl) - (Phenyl converted at position 4) Sulfonyl] -4-methyl piperazines

Info

Publication number
IL152927A
IL152927A IL15292799A IL15292799A IL152927A IL 152927 A IL152927 A IL 152927A IL 15292799 A IL15292799 A IL 15292799A IL 15292799 A IL15292799 A IL 15292799A IL 152927 A IL152927 A IL 152927A
Authority
IL
Israel
Prior art keywords
methyl
compound
reaction
title compound
propyl
Prior art date
Application number
IL15292799A
Other languages
English (en)
Hebrew (he)
Original Assignee
Pfizer Ireland Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10840421&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL152927(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Ireland Pharmaceuticals filed Critical Pfizer Ireland Pharmaceuticals
Publication of IL152927A publication Critical patent/IL152927A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
IL15292799A 1998-10-12 1999-10-07 1- [3- (7,6-Dihydro-1-methyl-7-oxo-3-profile-1H-pyrazolo [3,4-d] pyrimidin-5-yl) - (Phenyl converted at position 4) Sulfonyl] -4-methyl piperazines IL152927A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9822238.3A GB9822238D0 (en) 1998-10-12 1998-10-12 Process for preparation of pyrazolo[4,3-D]pyrimidin-7-ones and intermediates thereof
IL13227399A IL132273A (en) 1998-10-12 1999-10-07 -5 [(- 4-methyl-1-piperazinylsulfonyl) -2-benazamidomethmer] -1-methyl-3-profile-H1-ferrous-5-carboxamides, their preparation and process for the preparation of sildenafil from them

Publications (1)

Publication Number Publication Date
IL152927A true IL152927A (en) 2004-06-01

Family

ID=10840421

Family Applications (11)

Application Number Title Priority Date Filing Date
IL15292699A IL152926A (en) 1998-10-12 1999-10-07 Process for the preparation of 11 ethyl – 4 [–3 {3 ethyl 66, 77 dihydro - 7 - oxo - 2 - (pyridylmethyl) H2 - pyrazolo [4, 3 - [d pyrimidine - 5 - ile] propoxysulfonyl} - piperazine and intermediates –4 [2 Transformed –– 5 (–4 ethyl –– 1 piperazinylsulfonyl) - benzamide] - 5 - ethyl –– 1 (–2 pyridylmethyl) - H1 - pyrazole - 3 - carboxamide for it
IL15292399A IL152923A (en) 1998-10-12 1999-10-07 Acids-5 (–4 methyl –– 1-piperazinylsulfonyl) position-converted benzoic acids in position 2
IL13227399A IL132273A (en) 1998-10-12 1999-10-07 -5 [(- 4-methyl-1-piperazinylsulfonyl) -2-benazamidomethmer] -1-methyl-3-profile-H1-ferrous-5-carboxamides, their preparation and process for the preparation of sildenafil from them
IL152928A IL152928A (en) 1998-10-12 1999-10-07 1 - ethyl - 4 - [3 - [3 - ethyl - 6, 7 - dihydro - 7 oxo - 2 - (2 - pyridylmethyl) - 2H - pyrazolo [4, 3 - d] pyramidine - 5 - ile] (4 - Transformed phenyl (sulfonyl) piperazines
IL15292799A IL152927A (en) 1998-10-12 1999-10-07 1- [3- (7,6-Dihydro-1-methyl-7-oxo-3-profile-1H-pyrazolo [3,4-d] pyrimidin-5-yl) - (Phenyl converted at position 4) Sulfonyl] -4-methyl piperazines
IL15292499A IL152924A (en) 1998-10-12 1999-10-07 Acids-5 (-4-ethyl-1-piperazinylsulfonyl) position-converted benzoic acids in position 2
IL15292702A IL152927A0 (en) 1998-10-12 2002-11-18 Process for preparation of pyrazolo [4,3-d] pyrimidin-7-ones and intermediates thereof
IL15292802A IL152928A0 (en) 1998-10-12 2002-11-18 Process for preparation of pyrazolo [4,3-d] pyrimidin-7-ones and intermediates thereof
IL15292602A IL152926A0 (en) 1998-10-12 2002-11-18 Process for preparation of pyrazolo[4,3-d] pyrimidin-7-ones and intermediates thereof
IL15292302A IL152923A0 (en) 1998-10-12 2002-11-18 Process for preparation of pyrazolo[4,3-d] pyrimidin-7-ones and intermediates thereof
IL15292402A IL152924A0 (en) 1998-10-12 2002-11-18 Process for preparation of pyrazolo[4,3-d] pyrimidin-7-ones and intermediates thereof

Family Applications Before (4)

Application Number Title Priority Date Filing Date
IL15292699A IL152926A (en) 1998-10-12 1999-10-07 Process for the preparation of 11 ethyl – 4 [–3 {3 ethyl 66, 77 dihydro - 7 - oxo - 2 - (pyridylmethyl) H2 - pyrazolo [4, 3 - [d pyrimidine - 5 - ile] propoxysulfonyl} - piperazine and intermediates –4 [2 Transformed –– 5 (–4 ethyl –– 1 piperazinylsulfonyl) - benzamide] - 5 - ethyl –– 1 (–2 pyridylmethyl) - H1 - pyrazole - 3 - carboxamide for it
IL15292399A IL152923A (en) 1998-10-12 1999-10-07 Acids-5 (–4 methyl –– 1-piperazinylsulfonyl) position-converted benzoic acids in position 2
IL13227399A IL132273A (en) 1998-10-12 1999-10-07 -5 [(- 4-methyl-1-piperazinylsulfonyl) -2-benazamidomethmer] -1-methyl-3-profile-H1-ferrous-5-carboxamides, their preparation and process for the preparation of sildenafil from them
IL152928A IL152928A (en) 1998-10-12 1999-10-07 1 - ethyl - 4 - [3 - [3 - ethyl - 6, 7 - dihydro - 7 oxo - 2 - (2 - pyridylmethyl) - 2H - pyrazolo [4, 3 - d] pyramidine - 5 - ile] (4 - Transformed phenyl (sulfonyl) piperazines

Family Applications After (6)

Application Number Title Priority Date Filing Date
IL15292499A IL152924A (en) 1998-10-12 1999-10-07 Acids-5 (-4-ethyl-1-piperazinylsulfonyl) position-converted benzoic acids in position 2
IL15292702A IL152927A0 (en) 1998-10-12 2002-11-18 Process for preparation of pyrazolo [4,3-d] pyrimidin-7-ones and intermediates thereof
IL15292802A IL152928A0 (en) 1998-10-12 2002-11-18 Process for preparation of pyrazolo [4,3-d] pyrimidin-7-ones and intermediates thereof
IL15292602A IL152926A0 (en) 1998-10-12 2002-11-18 Process for preparation of pyrazolo[4,3-d] pyrimidin-7-ones and intermediates thereof
IL15292302A IL152923A0 (en) 1998-10-12 2002-11-18 Process for preparation of pyrazolo[4,3-d] pyrimidin-7-ones and intermediates thereof
IL15292402A IL152924A0 (en) 1998-10-12 2002-11-18 Process for preparation of pyrazolo[4,3-d] pyrimidin-7-ones and intermediates thereof

Country Status (49)

Country Link
US (3) US6207829B1 (bg)
EP (1) EP0994115B1 (bg)
JP (1) JP3721021B2 (bg)
KR (1) KR100380954B1 (bg)
CN (2) CN1207295C (bg)
AP (1) AP1233A (bg)
AR (1) AR019244A1 (bg)
AT (1) ATE290003T1 (bg)
AU (1) AU756463B2 (bg)
BG (1) BG63205B1 (bg)
BR (1) BR9905092A (bg)
CA (1) CA2285733C (bg)
CO (1) CO5150214A1 (bg)
CR (1) CR6118A (bg)
CU (1) CU22928A3 (bg)
CZ (1) CZ296816B6 (bg)
DE (1) DE69923906T2 (bg)
DK (1) DK0994115T3 (bg)
DZ (1) DZ2912A1 (bg)
EA (1) EA003774B1 (bg)
EE (1) EE04192B1 (bg)
EG (1) EG22630A (bg)
ES (1) ES2237049T3 (bg)
GB (1) GB9822238D0 (bg)
GE (1) GEP20022700B (bg)
GT (1) GT199900172A (bg)
HK (1) HK1027559A1 (bg)
HR (1) HRP990318B1 (bg)
HU (1) HU226162B1 (bg)
ID (1) ID23351A (bg)
IL (11) IL152926A (bg)
IS (1) IS1951B (bg)
MA (1) MA25007A1 (bg)
MY (1) MY124620A (bg)
NO (1) NO313700B1 (bg)
OA (1) OA11165A (bg)
PE (1) PE20001086A1 (bg)
PL (1) PL198150B1 (bg)
PT (1) PT994115E (bg)
RS (1) RS49762B (bg)
SG (1) SG118060A1 (bg)
SI (1) SI0994115T1 (bg)
SK (1) SK285215B6 (bg)
TN (1) TNSN99189A1 (bg)
TR (1) TR199902541A2 (bg)
TW (1) TW589314B (bg)
UA (1) UA66787C2 (bg)
UY (1) UY25750A1 (bg)
ZA (1) ZA996412B (bg)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5204800A (en) * 1999-06-21 2001-01-09 Biochemical Pharmaceutical Factory of Zhuhai Sez, The Process for preparing sildenafil, and troche which comprises sildenafil and apomorphine
US6667398B2 (en) 2000-06-22 2003-12-23 Pfizer Inc Process for the preparation of pyrazolopyrimidinones
JP2004501142A (ja) * 2000-06-22 2004-01-15 ファイザー・インク ピラゾロピリミジノンの製造方法
EP1176142A1 (en) * 2000-07-28 2002-01-30 Pfizer Inc. Process for the preparation of pyrazoles
US6407259B1 (en) 2000-07-28 2002-06-18 Pfizer Inc. Process for the preparation of pyrazoles
EP1176147A1 (en) * 2000-07-28 2002-01-30 Pfizer Limited Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-ones and intermediates thereof
PE20020394A1 (es) 2000-08-18 2002-06-21 Agouron Pharma Compuestos de pirazol y composiciones farmaceuticas que los contienen, que modulan y/o inhiben la actividad de erab/hadh2
US7335680B2 (en) * 2001-12-20 2008-02-26 Laboratoires Serono Sa Pyrrolidine derivatives as prostaglandin modulators
EP1503986B1 (en) * 2001-12-21 2015-09-30 Cytokinetics, Inc. Compositions and methods for treating heart failure
SI1509525T1 (sl) 2002-05-31 2006-12-31 Schering Corp Postopek priprave inhibitorjev ksantinske fosfodiesteraze V in njihovih prekurzorjev
WO2004072079A1 (en) * 2003-02-11 2004-08-26 Pfizer Limited Hydrated and anhydrous sildenafil hemi-citrate compound
ES2378620T3 (es) * 2003-03-27 2012-04-16 Cytokinetics, Inc. Sulfonamidas para el tratamiento de insuficiencia cardiaca congestiva, sus composiciones y usos.
CN100360531C (zh) * 2003-12-18 2008-01-09 中国人民解放军军事医学科学院放射与辐射医学研究所 用于预防或治疗阳萎和性冷淡的新吡唑并嘧啶类化合物
US20070010525A1 (en) * 2005-06-27 2007-01-11 Meyer Jackson Method and compositions for modulating neuropeptide hormone secretion
NL2000291C2 (nl) * 2005-11-10 2009-02-17 Pfizer Prod Inc 1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H- pyrazool(4,3-d)pyrimidine-5-yl)piperidine-4-carbonzuur en zouten daarvan.
EP2024369A4 (en) * 2006-06-05 2010-10-27 Matrix Lab Ltd NEW PROCESS FOR THE PREPARATION OF SILDENAFIL CITRATE
CZ308056B6 (cs) * 2015-07-20 2019-11-27 Ustav Experimentalni Botaniky Av Cr V V I 5-Substituované-7-[4-(substituované)benzyl]amino-3-isopropylpyrazolo[4,3-d]pyrimidiny, jejich použití jako antirevmatika, a farmaceutické přípravky
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
CN107759603B (zh) * 2016-08-18 2020-09-01 四川科伦药物研究院有限公司 一种杂环化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992441A (en) * 1972-12-26 1976-11-16 Pfizer Inc. Sulfamylbenzoic acids
GB9013750D0 (en) * 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
GB9612514D0 (en) * 1996-06-14 1996-08-14 Pfizer Ltd Novel process
PL336586A1 (en) * 1997-04-25 2000-07-03 Pfizer Pyrazoylpyrimidinones inhibiting the cyclic guanosine 3',5'-monophosphate phosphodiesterase of type 5 (cgmp pde5) for treating sexual disorders

Also Published As

Publication number Publication date
TW589314B (en) 2004-06-01
GT199900172A (es) 2001-03-28
BR9905092A (pt) 2000-08-08
EA003774B1 (ru) 2003-08-28
HK1027559A1 (en) 2001-01-19
PL335959A1 (en) 2000-04-25
CN1207295C (zh) 2005-06-22
CA2285733A1 (en) 2000-04-12
GEP20022700B (en) 2002-05-27
IL152923A (en) 2004-02-08
EA199900822A2 (ru) 2000-04-24
IS1951B (is) 2004-10-13
CO5150214A1 (es) 2002-04-29
CA2285733C (en) 2004-08-24
UA66787C2 (en) 2004-06-15
EA199900822A3 (ru) 2000-08-28
HUP9903469A3 (en) 2000-10-30
IL132273A (en) 2004-06-20
AU5358199A (en) 2000-04-13
US20010009962A1 (en) 2001-07-26
IL152924A0 (en) 2003-06-24
MA25007A1 (fr) 2000-07-01
EP0994115B1 (en) 2005-03-02
NO994943D0 (no) 1999-10-11
YU48999A (sh) 2002-06-19
TR199902541A2 (xx) 2000-07-21
IL152926A (en) 2004-02-19
EG22630A (en) 2003-05-31
ATE290003T1 (de) 2005-03-15
PE20001086A1 (es) 2000-10-18
HRP990318B1 (en) 2004-06-30
US20030069422A1 (en) 2003-04-10
AU756463B2 (en) 2003-01-16
IL152927A0 (en) 2003-06-24
HRP990318A2 (en) 2000-06-30
BG103794A (bg) 2000-09-29
IL152928A (en) 2007-07-04
CN1473831A (zh) 2004-02-11
BG63205B1 (bg) 2001-06-29
SK285215B6 (sk) 2006-09-07
GB9822238D0 (en) 1998-12-09
EE04192B1 (et) 2003-12-15
KR100380954B1 (ko) 2003-04-21
ID23351A (id) 2000-04-13
SG118060A1 (en) 2006-01-27
EP0994115A2 (en) 2000-04-19
AR019244A1 (es) 2001-12-26
SK138599A3 (en) 2000-05-16
NO994943L (no) 2000-04-13
DK0994115T3 (da) 2005-06-20
PL198150B1 (pl) 2008-05-30
EP0994115A3 (en) 2000-05-24
TNSN99189A1 (fr) 2005-11-10
OA11165A (en) 2003-04-22
IL152923A0 (en) 2003-06-24
UY25750A1 (es) 2001-08-27
PT994115E (pt) 2005-06-30
CN1255497A (zh) 2000-06-07
SI0994115T1 (bg) 2005-08-31
IL152924A (en) 2004-02-19
AP9901672A0 (en) 1999-12-31
CZ353299A3 (cs) 2000-05-17
DE69923906T2 (de) 2006-04-06
CU22928A3 (es) 2004-02-20
IS5209A (is) 2000-04-13
JP2000119273A (ja) 2000-04-25
HUP9903469A2 (hu) 2000-08-28
DZ2912A1 (fr) 2004-03-01
EE9900507A (et) 2000-06-15
ES2237049T3 (es) 2005-07-16
CR6118A (es) 2005-09-16
NO313700B1 (no) 2002-11-18
ZA996412B (en) 2001-04-11
IL132273A0 (en) 2001-03-19
CZ296816B6 (cs) 2006-06-14
JP3721021B2 (ja) 2005-11-30
DE69923906D1 (de) 2005-04-07
MY124620A (en) 2006-06-30
KR20000028987A (ko) 2000-05-25
RS49762B (sr) 2008-04-04
HU226162B1 (en) 2008-05-28
US6207829B1 (en) 2001-03-27
AP1233A (en) 2003-12-18
IL152928A0 (en) 2003-06-24
IL152926A0 (en) 2003-06-24
HU9903469D0 (en) 1999-12-28

Similar Documents

Publication Publication Date Title
US6207829B1 (en) Process for preparation of pyrazolo[4,3-d]pyrimidin-7-ones and intermediates thereof
EP0812845B1 (en) Process for preparing sildenafil
OA11495A (en) Process for the preparation of pyrazoloÄ4,3-dÜpyrimidin-7-ones-3-pyridylsulphonyl compounds and intermediates thereof.
US3862184A (en) N-substituted-1-(arylsulfinyl and arylsulfonyl)methanesulfonamides
MXPA99009326A (en) Procedure for the preparation of pirazolo [4,3-d] pyrimidin-7-onas and its intermed

Legal Events

Date Code Title Description
FF Patent granted
EXP Patent expired